Level Biotechnology (3118.TWO) Stock Price
Level Biotechnology Price
Revenue has compounded at 3.6% per year over the past 19 years to 736.59 M TWD. Earnings per share have grown at 3.2% per year over the last 19 years. Level Biotechnology's net margin stands at 10.8%, broadly stable from 10.1% several years earlier. Level Biotechnology currently offers a dividend yield of about 5.75%. The payout ratio is around 72% of earnings.
Level Biotechnology stock price
Level Biotechnology business model & stock analysis
Frequently asked questions about Level Biotechnology
Converted at the current exchange rate, the Level Biotechnology share trades at 0.88 EUR (31.30 TWD).
The revenue cannot currently be calculated for Level Biotechnology.
The profit cannot currently be calculated for Level Biotechnology.
The P/E ratio cannot be calculated for Level Biotechnology at the moment.
The P/S cannot be calculated for Level Biotechnology currently.
The Eulerpool Quality Score for Level Biotechnology is 4/10.
The ISIN of Level Biotechnology is TW0003118006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Level Biotechnology is 3118.TWO. The ticker symbol is used to trade Level Biotechnology shares on the stock exchange.
Level Biotechnology stock
Level Biotechnology Peer Group
Level Biotechnology FIGI
All fundamentals and in-depth analysis of Level Biotechnology
Our stock analysis for Level Biotechnology stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Level Biotechnology. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.